Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment.

Smith BW, Adams LA.

Nat Rev Endocrinol. 2011 May 10;7(8):456-65. doi: 10.1038/nrendo.2011.72. Review.

PMID:
21556019
2.

Nonalcoholic fatty liver disease: current issues and novel treatment approaches.

Lomonaco R, Sunny NE, Bril F, Cusi K.

Drugs. 2013 Jan;73(1):1-14. doi: 10.1007/s40265-012-0004-0. Review.

PMID:
23329465
3.

Non-alcoholic fatty liver disease.

Smith BW, Adams LA.

Crit Rev Clin Lab Sci. 2011 May-Jun;48(3):97-113. doi: 10.3109/10408363.2011.596521. Review.

PMID:
21875310
4.

Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals.

Masuoka HC, Chalasani N.

Ann N Y Acad Sci. 2013 Apr;1281:106-22. doi: 10.1111/nyas.12016. Epub 2013 Jan 30. Review.

5.

Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status.

Stein LL, Dong MH, Loomba R.

Adv Ther. 2009 Oct;26(10):893-907. doi: 10.1007/s12325-009-0072-z. Epub 2009 Nov 16. Review.

PMID:
19921118
6.

Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.

Shyangdan D, Clar C, Ghouri N, Henderson R, Gurung T, Preiss D, Sattar N, Fraser A, Waugh N.

Health Technol Assess. 2011 Nov;15(38):1-110. doi: 10.3310/hta15380. Review.

7.

Nonalcoholic fatty liver disease: a systematic review.

Rinella ME.

JAMA. 2015 Jun 9;313(22):2263-73. doi: 10.1001/jama.2015.5370. Review. Erratum in: JAMA. 2015 Oct 13;314(14):1521.

PMID:
26057287
8.

Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.

Schuppan D, Schattenberg JM.

J Gastroenterol Hepatol. 2013 Aug;28 Suppl 1:68-76. doi: 10.1111/jgh.12212. Review.

PMID:
23855299
9.

[Steatosis and steatohepatitis in diabetic patient].

Hůlek P, Dresslerová I.

Vnitr Lek. 2011 Apr;57(4):364-7. Review. Czech.

PMID:
21612059
10.

Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.

Younossi ZM.

Aliment Pharmacol Ther. 2008 Jul;28(1):2-12. doi: 10.1111/j.1365-2036.2008.03710.x. Epub 2008 Apr 11. Review.

11.

Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.

Cusi K.

Gastroenterology. 2012 Apr;142(4):711-725.e6. doi: 10.1053/j.gastro.2012.02.003. Epub 2012 Feb 8. Review.

PMID:
22326434
12.

Vitamin E and nonalcoholic fatty liver disease.

Pacana T, Sanyal AJ.

Curr Opin Clin Nutr Metab Care. 2012 Nov;15(6):641-8. doi: 10.1097/MCO.0b013e328357f747. Review.

13.

Non-alcoholic fatty liver disease in type 2 diabetes: pathogenesis and treatment options.

Tziomalos K, Athyros VG, Karagiannis A.

Curr Vasc Pharmacol. 2012 Mar;10(2):162-72. Review.

PMID:
22239625
14.

Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study.

Bell LN, Wang J, Muralidharan S, Chalasani S, Fullenkamp AM, Wilson LA, Sanyal AJ, Kowdley KV, Neuschwander-Tetri BA, Brunt EM, McCullough AJ, Bass NM, Diehl AM, Unalp-Arida A, Chalasani N; Nonalcoholic Steatohepatitis Clinical Research Network.

Hepatology. 2012 Oct;56(4):1311-8. doi: 10.1002/hep.25805. Epub 2012 Aug 21.

15.

Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?

Firneisz G.

World J Gastroenterol. 2014 Jul 21;20(27):9072-89. doi: 10.3748/wjg.v20.i27.9072. Review.

16.

New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD).

Ali R, Cusi K.

Ann Med. 2009;41(4):265-78. doi: 10.1080/07853890802552437. Review.

PMID:
19353360
17.

Non-alcoholic fatty liver disease: a diabetologist's perspective.

Pappachan JM, Antonio FA, Edavalath M, Mukherjee A.

Endocrine. 2014 Apr;45(3):344-53. doi: 10.1007/s12020-013-0087-8. Epub 2013 Nov 28. Review.

PMID:
24287794
18.

New treatments for nonalcoholic fatty liver disease.

Harrison SA.

Curr Gastroenterol Rep. 2006 Feb;8(1):21-9. Review.

PMID:
16510031
19.

Nonalcoholic fatty liver disease in India - a lot done, yet more required!

Duseja A.

Indian J Gastroenterol. 2010 Nov;29(6):217-25. doi: 10.1007/s12664-010-0069-1. Epub 2010 Dec 30. Review.

PMID:
21191681
20.

Nonalcoholic fatty liver disease.

Angulo P.

Rev Gastroenterol Mex. 2005 Nov;70 Suppl 3:52-6. Review.

PMID:
17471859

Supplemental Content

Support Center